FIELD: medicine.
SUBSTANCE: proposed group of inventions relates to medicine. Methods for isolating a high molecular weight protein complex for the activation of human caspase-2, formed in cancer cells in response to DNA-damaging chemotherapeutic treatment, are proposed. Cancer cells are incubated in the presence of a DNA-damaging chemotherapeutic drug until the maximum level of caspase-2 activation is obtained. Cells are harvested, followed by addition of a lysis buffer, separation of the cell debris from the lysate containing the high-molecular caspase-2 activation complex, separation by gel filtration of the resulting cell lysate, with the separation of fractions containing high-molecular forms of caspase-2 from fractions containing its monomeric forms and isolation from the fraction containing high-molecular forms of caspase-2, a high-molecular protein complex of caspase-2 activation.
EFFECT: proposed group of inventions provides an effective isolation of the complex of activation of human caspase-2.
36 cl, 5 tbl, 1 ex, 17 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PROCASPASE 3 ACTIVATION BY COMBINATION THERAPY | 2013 |
|
RU2659936C2 |
| METHOD FOR OBTAINING CASPASE-3 | 2022 |
|
RU2792795C1 |
| AGENT STIMULATING APOPTOSIS OF HUMAN LEUKAEMIA CELLS | 2007 |
|
RU2360692C1 |
| PROCASPASE COMBINED THERAPY WITH GLYBLASTOMA | 2013 |
|
RU2636234C2 |
| COMPOSITION AND METHOD OF TUMOUR CURING | 2007 |
|
RU2500815C2 |
| PROAPOPTOSIS PROTEINS-CONTAINING THERAPEUTIC AGENTS | 2002 |
|
RU2319709C2 |
| APOPTOSIS DETECTION TECHNIQUES AND REAGENTS | 2007 |
|
RU2450273C2 |
| COMBINED THERAPY PAC-1 | 2016 |
|
RU2720509C2 |
| INDUCTION OF APOPTOSIS IN TUMOUR CELLS, EXPRESSING TOLL-LIKE RECEPTOR | 2005 |
|
RU2401661C9 |
| ANALYSES AND METHODS OF BIOMARKER APPLICATION | 2006 |
|
RU2409817C2 |
Authors
Dates
2018-11-01—Published
2016-06-29—Filed